Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio
December 29, 2017 09:25 ET
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE) (“Galena”) announced today that its stockholders approved nine proposals at the reconvened Special Meeting...
Galena Will Adjourn Special Meeting until Friday, December 29, 2017, Urges Stockholders to Vote
December 14, 2017 17:03 ET
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), (“Galena”) announced today that its special meeting of stockholders (“Special Meeting”), scheduled for...
Galena Biopharma Reminds Shareholders to Vote Ahead of Special Meeting on December 15, 2017
December 08, 2017 14:50 ET
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE) would like to remind stockholders to vote their respective shares and support the business combination...
Galena Biopharma Reports Third Quarter 2017 Financial Results
November 09, 2017 16:30 ET
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
Galena Biopharma Announces Completion of Enrollment in Two NeuVax™ (nelipepimut-S) Clinical Trials in Combination with Trastuzumab
September 28, 2017 07:05 ET
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
Galena Biopharma and BioVascular, Inc. Reaffirm GALE-401 Partnership
September 11, 2017 07:05 ET
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
Galena Biopharma Reports Second Quarter 2017 Financial Results
August 14, 2017 16:30 ET
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group
August 08, 2017 06:00 ET
|
Galena Biopharma, Inc.
Merger to create a late-stage, NASDAQ-listed company focused on developing novel immune therapies for various types of cancerSELLAS’ lead asset, galinpepimut-S (GPS), is a Wilm’s Tumor 1...
Galena Biopharma Provides Corporate Update
July 12, 2017 06:30 ET
|
Galena Biopharma, Inc.
SAN RAMON, Calif., July 12, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
Galena Biopharma Reports First Quarter 2017 Financial Results
May 10, 2017 16:30 ET
|
Galena Biopharma, Inc.
SAN RAMON, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...